Blog
ISPE 2025: A real-world risk stratification approach to pulmonary embolism using Truveta Data
How AI and real-world data are rewriting the rare disease playbook
Truveta experts: Sudden cardiac arrest and arrhythmias among patients with chronic kidney disease
Unlocking treatment insights through real-world discontinuation data
Lyme disease peaks in June, remains high through August
Infection risk and adoption trends in hemodialysis catheters: New real-world evidence
GLP-1 RA prescription trends: January 2018 – June 2025
